Magnus Financial Group LLC Incyte Corp Transaction History

Magnus Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$85.07 - $109.69 $205,954 - $265,559	-2,421 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$74.18 - $108.93 $179,589 - $263,719	2,421 New	2,421 $252,000
Q1 2020 May 11, 2020	SELL	$63.18 - $85.97 $168,058 - $228,680	-2,660 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$73.04 - $95.72 $2,994 - $3,924	-41 Reduced 1.52%	2,660 $232,000
Q2 2019 Aug 05, 2019	SELL	$73.52 - $88.7 $3,823 - $4,612	-52 Reduced 1.89%	2,701 $229,000
Q1 2019 May 09, 2019	BUY	$63.56 - $88.17 $174,980 - $242,732	2,753 New	2,753 $237,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Magnus Financial Group LLC with notifications on news.